RespireRx Pharmaceuticals Inc (RSPI): Volatility RSPI Volatility, measured u...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

RespireRx Pharmaceuticals Inc (RSPI)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	34
Posts	1036
Boards Moderated	0
Alias Born	01/09/2013

Re: None

Thursday, 03/07/2024 10:01:49 AM

Thursday, March 07, 2024 10:01:49 AM

Volatility
RSPI
Volatility, measured using the width of the Bollinger Bands®, is extremely low, resulting in a condition called the Bollinger Band Squeeze. Bollinger Band Squeezes tend to precede major price breakouts, although they do not predict which direction the new trend will take. Trend and momentum indicators can be useful during Squeeze conditions to help discern the direction of future trends.

Respirerx Pharmaceut RSPI: OTC Markets

Pharmaceuticals

$0.0010$0.0000(0.00%)

Market open: 9:50:30 AM ET, 03/07/2024

Bid/Size

$0.0009/75,952

Ask/Size

$0.0010/40,000

Previous close

$0.0010

Today's open

$0.0009

Today's volume

6MBelow Avg.

Today's range

$0.0009$0.0010

52-week range

$0.0006$0.0191

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM

More RSPI News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow